{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:22:47Z","timestamp":1794579767759,"version":"4.9.1"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000882","name":"University of Aberdeen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Previous attempts to pool prevalence studies in PsA have failed to take account of important methodological differences between studies that may have created biased estimates. The aim of this review is to estimate the prevalence of PsA within the adult general population worldwide, considering potential differences between population-based and health administrative studies separately.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Four electronic databases were systematically searched for articles reporting the prevalence of PsA. Data were pooled to generate worldwide prevalence estimates. Where sufficient data were available, results were summarized by continent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty studies were identified, with half from Europe (n\u2009=\u200915). Thirteen population-based studies were identified comprising &amp;gt;92\u2009000 adults, plus 17 studies (&amp;gt;180 million adults) based on health administrative data. The worldwide prevalence of PsA was 112 per 100\u2009000 adults. The prevalence of PsA estimated using population-based studies was 113 per 100\u2009000 with continent-specific estimates of 207 (Europe), 64 (North America) and 37 (Asia) per 100\u2009000. Health administrative studies gave a global prevalence of 109 per 100\u2009000 with continent-specific prevalence of 175 (Europe), 147 (North America), 78 (Asia) and 17 (South America).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review compiles currently available estimates of PsA prevalence in the general population into global and continent-based estimates and considers important study design characteristics. There is wide variability between continents, and data in some geographical areas are sparse, but available evidence suggests that PsA is more common in Europe and North America compared with Asia and South America, and current best estimates suggest a global prevalence of 112 per 100\u2009000 adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae198","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T19:14:27Z","timestamp":1711134867000},"page":"3211-3220","source":"Crossref","is-referenced-by-count":73,"title":["The worldwide prevalence of psoriatic arthritis\u2014a systematic review and meta-analysis"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0426-0312","authenticated-orcid":false,"given":"Stephanie","family":"Lembke","sequence":"first","affiliation":[{"name":"Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen , Aberdeen,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-3314","authenticated-orcid":false,"given":"Gary J","family":"Macfarlane","sequence":"additional","affiliation":[{"name":"Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen , Aberdeen,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-7591","authenticated-orcid":false,"given":"Gareth T","family":"Jones","sequence":"additional","affiliation":[{"name":"Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen , Aberdeen,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"2024121222475365400_keae198-B1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2024121222475365400_keae198-B2","first-page":"100519","article-title":"Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic health record data","volume":"23","author":"Scott","year":"2022","journal-title":"Lancet Reg Health\u2014Eur"},{"key":"2024121222475365400_keae198-B3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2024121222475365400_keae198-B4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semarthrit.2018.01.003","article-title":"Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis","volume":"48","author":"Scotti","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2024121222475365400_keae198-B5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2024121222475365400_keae198-B6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/bjd.13908","article-title":"Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register","volume":"173","author":"Iskandar","year":"2015","journal-title":"Br J Dermatol"},{"key":"2024121222475365400_keae198-B7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"2024121222475365400_keae198-B8","author":"Lembke"},{"key":"2024121222475365400_keae198-B9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.NAJ.0000451683.66447.89","article-title":"JBI\u2019s systematic reviews: data extraction and synthesis","volume":"114","author":"Munn","year":"2014","journal-title":"AJN Am J Nurs"},{"key":"2024121222475365400_keae198-B10","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/MIB.0000000000000153","article-title":"Epidemiology and health administrative data: focus on methodology and transparency","volume":"20","author":"Benchimol","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2024121222475365400_keae198-B11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2024121222475365400_keae198-B12","volume-title":"Applied social research methods","author":"Lipsey","year":"2001"},{"key":"2024121222475365400_keae198-B13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"key":"2024121222475365400_keae198-B14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2024121222475365400_keae198-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting Meta-Analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"2024121222475365400_keae198-B16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2024121222475365400_keae198-B17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2004.029207","article-title":"Prevalence of spondyloarthropathies in France: 2001","volume":"64","author":"Saraux","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2024121222475365400_keae198-B18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10067-005-1106-9","article-title":"Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study","volume":"24","author":"Trontzas","year":"2005","journal-title":"Clin Rheumatol"},{"key":"2024121222475365400_keae198-B19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/03009740600904243","article-title":"Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study","volume":"36","author":"De Angelis","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"2024121222475365400_keae198-B20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2474-11-98","article-title":"The prevalence of rheumatic diseases in central Greece: a population survey","volume":"11","author":"Anagnostopoulos","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"2024121222475365400_keae198-B21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00296-010-1699-4","article-title":"The prevalences of some rheumatic diseases in western Turkey: Havsa study","volume":"32","author":"\u00c7ak\u0131r","year":"2012","journal-title":"Rheumatol Int"},{"key":"2024121222475365400_keae198-B22","first-page":"254","article-title":"Psoriatic arthritis and ankylosing spondylitis impact on health-related quality of life and working life","volume":"44","author":"Rodrigues","year":"2019","journal-title":"Acta Reumatol Port"},{"key":"2024121222475365400_keae198-B23","doi-asserted-by":"crossref","first-page":"e0234556","DOI":"10.1371\/journal.pone.0234556","article-title":"Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study","volume":"15","author":"Romero P\u00e9rez","year":"2020","journal-title":"PLoS ONE"},{"key":"2024121222475365400_keae198-B24","first-page":"2252","article-title":"Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study","volume":"30","author":"Hoa","year":"2003","journal-title":"J Rheumatol"},{"key":"2024121222475365400_keae198-B25","first-page":"177","article-title":"Musculoskeletal pain, disability and health-seeking behavior in adult Kuwaitis using a validated Arabic version of the WHO-ILAR COPCORD Core Questionnaire","volume":"22","author":"Al-Awadhi","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"2024121222475365400_keae198-B26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3899\/jrheum.080675","article-title":"Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune Region of India using the COPCORD Bhigwan model","volume":"36","author":"Joshi","year":"2009","journal-title":"J Rheumatol"},{"key":"2024121222475365400_keae198-B27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/rheumatology\/ker370","article-title":"Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing","volume":"51","author":"Li","year":"2012","journal-title":"Rheumatology"},{"key":"2024121222475365400_keae198-B28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3899\/jrheum.100954","article-title":"Prevalence of musculoskeletal pain and rheumatic diseases in the Southeastern Region of Mexico. A COPCORD-based community survey","volume":"86","author":"Alvarez-Nemegyei","year":"2011","journal-title":"J Rheumatol Suppl"},{"key":"2024121222475365400_keae198-B29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3899\/jrheum.100952","article-title":"Epidemiology of rheumatic diseases. a community-based study in urban and rural populations in the State of Nuevo Leon, Mexico","volume":"86","author":"Rodriguez-Amado","year":"2011","journal-title":"J Rheumatol Suppl"},{"key":"2024121222475365400_keae198-B30","first-page":"2641","article-title":"Epidemiology of psoriatic arthritis in Northwest Greece, 1982\u2013200","volume":"30","author":"Alamanos","year":"2003","journal-title":"J Rheumatol"},{"key":"2024121222475365400_keae198-B31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/03009740903544212","article-title":"Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic","volume":"39","author":"Hanova","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"2024121222475365400_keae198-B32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3899\/jrheum.180670","article-title":"Burden and disease characteristics of patients with psoriatic arthritis: a population-based cross-sectional study","volume":"46","author":"Tekin","year":"2019","journal-title":"J Rheumatol"},{"key":"2024121222475365400_keae198-B33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12325-020-01522-8","article-title":"Epidemiology and treatment of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis in Germany: a real-world evidence study","volume":"38","author":"Grellmann","year":"2021","journal-title":"Adv Ther"},{"key":"2024121222475365400_keae198-B34","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/rheumatology\/keaa448","article-title":"Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database","volume":"60","author":"Pina Vegas","year":"2021","journal-title":"Rheumatology"},{"key":"2024121222475365400_keae198-B35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/03009742.2021.1997436","article-title":"Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents","volume":"52","author":"Kerola","year":"2023","journal-title":"Scand J Rheumatol"},{"key":"2024121222475365400_keae198-B36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3899\/jrheum.221139","article-title":"The national prevalence of clinically diagnosed psoriatic arthritis in Sweden 2017","volume":"50","author":"Exarchou","year":"2023","journal-title":"J Rheumatol"},{"key":"2024121222475365400_keae198-B37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13075-017-1497-4","article-title":"The epidemiology of psoriatic arthritis in Israel\u2014a population-based study","volume":"20","author":"Eder","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2024121222475365400_keae198-B38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3899\/jrheum.170516","article-title":"Epidemiology and medication pattern change of psoriatic diseases in Taiwan from 2000 to 2013: a nationwide, population-based cohort study","volume":"45","author":"Wei","year":"2018","journal-title":"J Rheumatol"},{"key":"2024121222475365400_keae198-B39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pds.3447","article-title":"Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009: OCCURRENCE OF PSORIASIS AND PSORIATIC ARTHRITIS","volume":"22","author":"Asgari","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024121222475365400_keae198-B40","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/acr.23743","article-title":"Trends in the Prevalence and Incidence of Psoriasis and Psoriatic Arthritis in Ontario, Canada: A Population-Based Study","volume":"71","author":"Eder","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2024121222475365400_keae198-B41","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/art.41741","article-title":"The epidemiology of psoriatic arthritis over five decades: a population-based study","volume":"73","author":"Karmacharya","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2024121222475365400_keae198-B42","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s40744-021-00370-4","article-title":"Racial differences in prevalence and treatment for psoriatic arthritis and ankylosing spondylitis by insurance coverage in the USA","volume":"8","author":"Ogdie","year":"2021","journal-title":"Rheumatol Ther"},{"key":"2024121222475365400_keae198-B43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/rheumatology\/keq369","article-title":"Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study","volume":"50","author":"Soriano","year":"2011","journal-title":"Rheumatology"},{"key":"2024121222475365400_keae198-B44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2991\/jegh.k.190920.001","article-title":"Population-based Study of 24 Autoimmune diseases carried out in a Brazilian Microregion","volume":"9","author":"J\u00fanior","year":"2019","journal-title":"J Epidemiol Glob Health"},{"key":"2024121222475365400_keae198-B45","first-page":"S1","article-title":"Prevalence and demographic characteristics of psoriatic arthritis in Colombia: data from the National Health Registry 2012\u20132018Prevalence and demographic characteristics of psoriatic arthritis in Colombia: data from the National Health Registry 2012-2018","volume":"30","author":"Fern\u00e1ndez-\u00c1vila","year":"2023","journal-title":"Colomb J Rheumatol"},{"key":"2024121222475365400_keae198-B46","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/ard.2010.141598","article-title":"Prevalence of spondyloarthritis and its subtypes in southern Sweden","volume":"70","author":"Haglund","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024121222475365400_keae198-B47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/rheumatology\/kes324","article-title":"Prevalence and treatment patterns of psoriatic arthritis in the UK","volume":"52","author":"Ogdie","year":"2013","journal-title":"Rheumatology"},{"key":"2024121222475365400_keae198-B48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00296-020-04734-x","article-title":"Trends in psoriatic arthritis epidemiology in Poland","volume":"41","author":"T\u0142ustochowicz","year":"2021","journal-title":"Rheumatol Int"},{"key":"2024121222475365400_keae198-B49","doi-asserted-by":"crossref","first-page":"adv00807","DOI":"10.2340\/actadv.v102.1962","article-title":"Incidence, prevalence, and mortality of people with psoriasis and psoriatic arthritis in Taiwan: a nationwide cohort study","volume":"102","author":"Iskandar","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"2024121222475365400_keae198-B50","first-page":"554","article-title":"Spondyloarthropathies in Japan: nationwide questionnaire survey performed by The Japan Ankylosing Spondylitis Society","volume":"28","author":"Hukuda","year":"2001","journal-title":"J Rheumatol"},{"key":"2024121222475365400_keae198-B51","first-page":"e78","article-title":"The lack of statistical power of subgroup analyses in meta-analyses: a cautionary note","volume":"30","author":"Cuijpers","year":"2021","journal-title":". Cambridge: Cambridge University Press,"},{"key":"2024121222475365400_keae198-B52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum"},{"key":"2024121222475365400_keae198-B53","first-page":"645p","volume-title":"Arthritis and allied conditions","author":"Bennett","year":"1979","edition":"9th ed"},{"key":"2024121222475365400_keae198-B54","first-page":"151","volume-title":"Spondyloarthropathies","author":"Vasey","year":"1984"},{"key":"2024121222475365400_keae198-B55","first-page":"127","article-title":"Psoriatic arthritis (PSA)\u2014an analysis of 220 patients","volume":"62","author":"Gladman","year":"1987","journal-title":"Q J Med"},{"key":"2024121222475365400_keae198-B56","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"2024121222475365400_keae198-B57","first-page":"446","article-title":"Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients","volume":"66","author":"Fourni\u00e9","year":"1999","journal-title":"Rev Rhum Engl Ed"},{"key":"2024121222475365400_keae198-B58","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO;2-7","article-title":"Psoriatic arthritis: a unified concept twenty years on","volume":"42","author":"McGonagle","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2024121222475365400_keae198-B59","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2024121222475365400_keae198-B60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/leap.1210","article-title":"How can we ensure visibility and diversity in research contributions? How the Contributor Role Taxonomy (CRediT) is helping the shift from authorship to contributorship","volume":"32","author":"Allen","year":"2019","journal-title":"Learn Publ"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae198\/58120194\/keae198.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/12\/3211\/60903520\/keae198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/12\/3211\/60903520\/keae198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:48:19Z","timestamp":1734025699000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/12\/3211\/7635171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,3,26]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae198","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,3,26]]}}}